![Igor Edouard Fisch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Igor Edouard Fisch
Gründer bei Selexis SA
Aktive Positionen von Igor Edouard Fisch
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Selexis SA
![]() Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Direktor/Vorstandsmitglied | - | - |
Gründer | 21.01.2010 | - | |
Vorstandsvorsitzender | - | 16.10.2020 | |
Vorsitzender | 09.03.2001 | - | |
Venturelab AG
![]() Venturelab AG Investment ManagersFinance Venturelab AG (Venturelab) is an independent venture capital firm headquartered in Schliren, Switzerland. The firm was founded by Beat Schillig and Jordi Monserrat in 2001. | Corporate Officer/Principal | - | - |
Karriereverlauf von Igor Edouard Fisch
Ehemalige bekannte Positionen von Igor Edouard Fisch
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Affitech A/S
![]() Affitech A/S Pharmaceuticals: MajorHealth Technology Affitech A/S engages in the development of human antibody therapeutics. It focuses on human antibodies for cancer such as hematological and solid tumors; and serious inflammatory conditions including rheumatoid arthritis and severe asthma. The firm enters into partnerships and collaborations with biotechnology companies for antibody discovery and development. The company was founded by Søren Mouritsen and Henrik Irgang Elsner on October 1, 1990 and is headquartered in Copenhagen, Denmark. | Direktor/Vorstandsmitglied | 14.07.2011 | - |
Independent Dir/Board Member | 28.04.2011 | - | |
Viroblock SA
![]() Viroblock SA Miscellaneous Commercial ServicesCommercial Services Viroblock SA develops and commercializes antiviral products. Viroblock technology uses a novel mechanism of action to inactivate enveloped viruses, human and avian such As influenzas, SARS virus and the AIDS virus. The company was founded by Donald F. H. Wallach in 2005 and is headquartered in Irvine, CA. | Direktor/Vorstandsmitglied | - | 28.07.2009 |
Corporate Officer/Principal | 28.07.2009 | 11.05.2011 |
Ausbildung von Igor Edouard Fisch
University of Cambridge | Doctorate Degree |
Statistik
International
Schweiz | 4 |
Vereinigtes Königreich | 2 |
Dänemark | 2 |
Operativ
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Sektoral
Commercial Services | 3 |
Consumer Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Viroblock SA
![]() Viroblock SA Miscellaneous Commercial ServicesCommercial Services Viroblock SA develops and commercializes antiviral products. Viroblock technology uses a novel mechanism of action to inactivate enveloped viruses, human and avian such As influenzas, SARS virus and the AIDS virus. The company was founded by Donald F. H. Wallach in 2005 and is headquartered in Irvine, CA. | Commercial Services |
Selexis SA
![]() Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Commercial Services |
Affitech A/S
![]() Affitech A/S Pharmaceuticals: MajorHealth Technology Affitech A/S engages in the development of human antibody therapeutics. It focuses on human antibodies for cancer such as hematological and solid tumors; and serious inflammatory conditions including rheumatoid arthritis and severe asthma. The firm enters into partnerships and collaborations with biotechnology companies for antibody discovery and development. The company was founded by Søren Mouritsen and Henrik Irgang Elsner on October 1, 1990 and is headquartered in Copenhagen, Denmark. | Health Technology |
Venturelab AG
![]() Venturelab AG Investment ManagersFinance Venturelab AG (Venturelab) is an independent venture capital firm headquartered in Schliren, Switzerland. The firm was founded by Beat Schillig and Jordi Monserrat in 2001. | Finance |
- Börse
- Insiders
- Igor Edouard Fisch
- Erfahrung